Mittmann, Nicole; Oh, Paul I.; Walker, Scott E.; … - In: PharmacoEconomics 22 (2004) 10, pp. 671-683
thromboembolism or increase bleeding risk in patients with atrial fibrillation. Objective: To compare the cost effectiveness of … related to atrial fibrillation. Design: A Markov decision-analytic model simulating health and economic outcomes over 1 year … acceptable limits (thromboembolism and bleeds 7. 1% vs 9.3%). Conclusions: In patients with atrial fibrillation and a prior …